Parkinson's disease

Today's Parkinson's Unity Walk was opened by Michael J. Fox!The 18th Annual Parkinson's Unity Walk (PUW) was held today Saturday, April 28, 2012 in New York City's Central Park. The PUW is the largest grassroots awareness and fundraising event for Parkinson's disease (PD) research in the United States. The event, which has grown from 200 participants in its inaugural year, is expected to unite more than 10,000 participants from across the globe."The annual Parkinson's Unity Walk is a powerful...Read Full Story

Researchers from the Parkinson’s Institute in Sunnyvale, California have discovered a possible connection between trichloroethylene (TCE) exposure and an increased risk for Parkinson’s disease. Their study entitled “Solvent Exposures and Parkinson Disease Risk in Twins” was recently published in the Annals of Neurology Journal and is the first ever study to suggest a “significant association” between TCE and Parkinson’s. A research team led by Drs. Caroline Tanner and Samuel Goldman...Read Full Story

Deprenyl is a nootropic drug also known as smart drugs for their ability to improve brain function, increase concentration, enhance mood and sharpen memory. Deprenyl also known as selepryl or selegiline citrate is a neuro-protective medicine which is mostly used for the treatment of early-stage Parkinson's disease, depression, anxiety and senile dementia.Though use of Deprenyl or selepryl is not stated for the treatment of alzhiemer’s disease, its benefit in alzheimer’s disease treatment is...Read Full Story

Deep Brain Stimulation: A New Life for People with Parkinson's, Dystonia and Essential Tremor by Kelvin L. Chou, Susan Grube, Parag Patil Publication Date: January 17, 2012 Buy new: $19.95 $13.57 17 used & new from $8.19(Visit the Hot New Releases in Parkinson's Disease list for authoritative information on this product's current rank.)Check Price and Read MoreRead Full Story

Children thrived after results found they had a subtype of disease requiring different treatment Share What is this? Twitter Digg Facebook More... EMAIL PRINT RSS   WEDNESDAY, June 15 (HealthDay News) -- Twins with a rare disorder that left one of them unable to walk are now playing soccer and running track, thanks in part to cutting-edge technology known as whole-genome sequencing that enabled physicians to better treat the disorder. Soon after Alexis and Noah Beery...Read Full Story

CHICAGO (Reuters) - When Noah and Alexis Beery were diagnosed with cerebral palsy nearly 13 years ago, the diagnosis never sat right with the twins' mother, Retta Beery.Her lengthy search for the true cause of her children's strange collection of symptoms finally led to an answer when a scan of the twins' genomes turned up a genetic defect that caused the children's disorder and finally led to the right treatment.The investigation offers a rare glimpse at the potential of whole genome...Read Full Story

CHICAGO (Reuters) - When Noah and Alexis Beery were diagnosed with cerebral palsy nearly 13 years ago, the diagnosis never sat right with the twins' mother, Retta Beery.Her lengthy search for the true cause of her children's strange collection of symptoms finally led to an answer when a scan of the twins' genomes turned up a genetic defect that caused the children's disorder and finally led to the right treatment.The investigation offers a rare glimpse at the potential of whole genome...Read Full Story

Considered to be one of the most promising methods of managing Parkinson’s Disease, Deep Brain Stimulation is gaining due popularity for the past decade or so. Delivering remarkable results for the patients suffering from advanced Parkinson’s disease and other neurological movement disorders, Deep Brain Stimulation (DBS) is a surgical procedure that includes implanting a battery operated medical device known as a neurostimulator into a specific part of the patient’s brain (usually the...Read Full Story

A diagnosis of Parkinsons disease is one of the hardest things you will ever have to deal with. It is caused by the death of dopamine-generating cells in the substantia nigra, a region of the midbrain. The many years doctors have spent researching this disease haven’t generated a cause for this cell death. No lab test exists to clearly determine whether a patient has the disease. Brain scans cross diseases that may cause similar symptoms off the list, increasing the chance of a more accurate...Read Full Story

Regimens improved movement and coordination, and reduced tremors Share What is this? Twitter Digg Facebook More... EMAIL PRINT RSS   TUESDAY, April 12 (HealthDay News) -- The difficulties with walking, movement and coordination that Parkinson's patients struggle with might be partially offset by a new drug combination and a different approach to exercise, researchers suggest. Parkinson's patients may achieve the greatest improvements in gait and mobility from lengthy...Read Full Story